Trademark: 88521914
Status Date
Tuesday, June 28, 2022
Registration Number
6770342
Registration Date
Tuesday, June 28, 2022
Filing Date
Thursday, July 18, 2019
Published for Opposition
Tuesday, April 12, 2022
5 Pharmaceutical preparations for the treatment of pancreatic tumors; pharmaceutical agents for the treatment of disorders in sensory organs; thyroid and para-thyroid hormone preparations; medicinal tonics for the treatment of pancreatic tumors; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents for use in regulating metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anaesthetics; pharmaceutical for use in the treating disorders of the peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms for medical purposes; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for treating disorders of the urogenital organs; vitamin preparations; pharmaceutical preparations for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents for treating disorders of the digestive organs; pharmaceutical preparations for the treatment of cardiovascular disorders; nervines; ophthalmic preparations; allergy medications; chemicopharmaceutical preparations for the treatment of pancreatic disorders; medicines for the treatment of gastrointestinal diseases; mineral injection preparations featuring vitamin supplements for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; suppositories; pharmaceutical preparations for use in the treatment of disorders of the central nervous system; pharmaceutical preparations for diagnosis of cancer; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for treating tooth pain; hemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treatment of hemorrhoids; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood solvent being preparations for treating blood disorders; pharmaceutical preparations for treating disorders of the respiratory organs; respiratory stimulant preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for the treatment of rhinitis; pharmaceutical products for the treatment of bone diseases; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cancerous cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated preparations for the treatment of mouth disorders; transdermal patches for medical treatment of nausea; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of gout; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Apr 18, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 18, 2023
Teas Change Of Correspondence Received
Apr 18, 2023
Teas Change Of Domestic Representatives Address
Apr 18, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 18, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 18, 2023
Teas Change Of Owner Address Received
Jun 28, 2022
Notice Of Registration Confirmation Emailed
Jun 28, 2022
Registered-Principal Register
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Apr 11, 2022
Suspension Checked ¿ To Attorney For Action
Apr 5, 2022
Suspension Checked ¿ To Attorney For Action
Mar 28, 2022
Suspension Checked ¿ To Attorney For Action
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 21, 2022
Suspension Checked ¿ To Attorney For Action
Mar 14, 2022
Suspension Checked ¿ To Attorney For Action
Mar 7, 2022
Suspension Checked ¿ To Attorney For Action
Mar 5, 2022
Approved For Pub - Principal Register
Feb 28, 2022
Suspension Checked ¿ To Attorney For Action
Jul 30, 2021
Report Completed Suspension Check Case Still Suspended
Oct 13, 2020
Notification Of Letter Of Suspension E-Mailed
Oct 13, 2020
Letter Of Suspension E-Mailed
Oct 13, 2020
Suspension Letter Written
Oct 13, 2020
Teas/Email Correspondence Entered
Oct 13, 2020
Correspondence Received In Law Office
Oct 9, 2020
Teas Response To Office Action Received
May 19, 2020
Notification Of Non-Final Action E-Mailed
May 19, 2020
Non-Final Action E-Mailed
May 19, 2020
Non-Final Action Written
Apr 17, 2020
Teas/Email Correspondence Entered
Apr 17, 2020
Correspondence Received In Law Office
Apr 17, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 16, 2020
Assigned To Lie
Apr 9, 2020
Teas Response To Office Action Received
Nov 26, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 26, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 10, 2019
Notification Of Non-Final Action E-Mailed
Oct 10, 2019
Non-Final Action E-Mailed
Oct 10, 2019
Non-Final Action Written
Oct 7, 2019
Assigned To Examiner
Jul 25, 2019
New Application Office Supplied Data Entered
Jul 22, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
